Search

Your search keyword '"HIV Envelope Protein gp120 metabolism"' showing total 2,461 results

Search Constraints

Start Over You searched for: Descriptor "HIV Envelope Protein gp120 metabolism" Remove constraint Descriptor: "HIV Envelope Protein gp120 metabolism"
2,461 results on '"HIV Envelope Protein gp120 metabolism"'

Search Results

201. Protein structural disorder of the envelope V3 loop contributes to the switch in human immunodeficiency virus type 1 cell tropism.

202. The β20-β21 of gp120 is a regulatory switch for HIV-1 Env conformational transitions.

203. Extracellular Matrix Proteins Mediate HIV-1 gp120 Interactions with α 4 β 7 .

204. A Degraded Fragment of HIV-1 Gp120 in Rat Hepatocytes Forms Fibrils and Enhances HIV-1 Infection.

205. Layer-by-Layer Engineered Microbicide Drug Delivery System Targeting HIV-1 gp120: Physicochemical and Biological Properties.

206. Effects of nanoparticle-encapsulated curcumin on HIV-gp120-associated neuropathic pain induced by the P2X 3 receptor in dorsal root ganglia.

207. The P2X 7 receptor in dorsal root ganglia is involved in HIV gp120-associated neuropathic pain.

208. Determinants of HIV-1 CD4-Independent Brain Adaptation.

209. Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.

210. Human Immunodeficiency Virus and Simian Immunodeficiency Virus Maintain High Levels of Infectivity in the Complete Absence of Mucin-Type O-Glycosylation.

211. Broadly neutralizing antibodies targeting the HIV-1 envelope V2 apex confer protection against a clade C SHIV challenge.

212. Endocytic Trafficking of HIV gp120 is Mediated by Dynamin and Plays a Role in gp120 Neurotoxicity.

213. CD4-gp120 interaction interface - a gateway for HIV-1 infection in human: molecular network, modeling and docking studies.

214. Effect of naringin on gp120-induced injury mediated by P2X7 receptors in rat primary cultured microglia.

215. 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol} (TIMBD) suppresses HIV1-gp120 mediated production of IL6 and IL8 but not CCL5.

216. Non-neutralizing Antibodies Alter the Course of HIV-1 Infection In Vivo.

217. Design of HIV Coreceptor Derived Peptides That Inhibit Viral Entry at Submicromolar Concentrations.

218. Glycosylation and oligomeric state of envelope protein might influence HIV-1 virion capture by α4β7 integrin.

219. Host protein atlastin-1 promotes human immunodeficiency virus (HIV-1) replication.

220. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.

221. The Myxobacterial Metabolite Soraphen A Inhibits HIV-1 by Reducing Virus Production and Altering Virion Composition.

222. Discovery and Characterization of a Novel CD4-Binding Adnectin with Potent Anti-HIV Activity.

223. Virus versus virus.

224. Methamphetamine potentiates HIV-1gp120-induced microglial neurotoxic activity by enhancing microglial outward K + current.

225. Conformational Heterogeneity of the HIV Envelope Glycan Shield.

226. Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.

227. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.

228. Antiviral Activity of Dual-acting Hydrocarbon-stapled Peptides against HIV-1 Predominantly Circulating in China.

229. Small-molecule HIV-1 entry inhibitors targeting gp120 and gp41: a patent review (2010-2015).

230. A Versatile Tool for Live-Cell Imaging and Super-Resolution Nanoscopy Studies of HIV-1 Env Distribution and Mobility.

231. Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop.

232. Molecular Features of the V1-V4 Coding Region of Sexually Transmitted Human Immunodeficiency Virus Type 1.

233. Extracellular Vesicles Carry HIV Env and Facilitate Hiv Infection of Human Lymphoid Tissue.

234. Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664.

235. Conformational States of a Soluble, Uncleaved HIV-1 Envelope Trimer.

236. A non-canonical binding interface in the crystal structure of HIV-1 gp120 core in complex with CD4.

237. IFNβ Protects Neurons from Damage in a Murine Model of HIV-1 Associated Brain Injury.

238. Insights from NMR Spectroscopy into the Conformational Properties of Man-9 and Its Recognition by Two HIV Binding Proteins.

239. Synthesis, Antiviral Potency, in Vitro ADMET, and X-ray Structure of Potent CD4 Mimics as Entry Inhibitors That Target the Phe43 Cavity of HIV-1 gp120.

240. Free Energy Perturbation Calculation of Relative Binding Free Energy between Broadly Neutralizing Antibodies and the gp120 Glycoprotein of HIV-1.

241. Accurate predictions of population-level changes in sequence and structural properties of HIV-1 Env using a volatility-controlled diffusion model.

242. A317491 relieved HIV gp120-associated neuropathic pain involved in P2X 3 receptor in dorsal root ganglia.

243. Quaternary contact in the initial interaction of CD4 with the HIV-1 envelope trimer.

244. Global site-specific N-glycosylation analysis of HIV envelope glycoprotein.

245. HIV-1 gp120 envelope glycoprotein determinants for cytokine burst in human monocytes.

246. Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library.

247. Delineating CD4 dependency of HIV-1: Adaptation to infect low level CD4 expressing target cells widens cellular tropism but severely impacts on envelope functionality.

248. Position 22 of the V3 loop is associated with HIV infectivity.

249. Structural Analysis of the Glycosylated Intact HIV-1 gp120-b12 Antibody Complex Using Hydroxyl Radical Protein Footprinting.

250. Global N-Glycan Site Occupancy of HIV-1 gp120 by Metabolic Engineering and High-Resolution Intact Mass Spectrometry.

Catalog

Books, media, physical & digital resources